Bokf, NA
- SEC CIK
- 0000009634
- Latest filing
- Aug 10, 2026
TCRT holding history
Alaunos Therapeutics, Inc. in every 13F filed by Bokf, NA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRT overviewAll 13F holders of TCRTFull Q2 2026 holdings
- Shares (Q2 2026)
- 66
- Value
- $149
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 66 | $149 | <0.1% | +66 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −66−100.0% | Sold out | Holders |
| Q2 2025 | 66 | $320 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 66 | $97 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 66 | $112 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 66 | $181 | <0.1% | +66 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −667−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q4 2023 | 10,000 | $707 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,000 | $800 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,000 | $5.10K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,000 | $6.30K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,000 | $6.49K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,000 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,000 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,000 | $7.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,000 | $11.0K | <0.1% | −2,697−21.2% | Reduced | Holders |
| Q3 2021 | 12,697 | $23.0K | <0.1% | – | No prior filing | Holders |
| Q2 2021 | – | – | – | – | Not filed | Holders |
| Q1 2021 | 10,000 | $36.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.